Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)

About FMS

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery o…

Sector

Health Care

Industry

Misc Health and Biotechnology Services

Employees

107,226

Website

www.freseniusmedicalcare.com/

Fundamentals

1-day range

$24.13$24.41

Market cap

$13.46B

P/E (trailing)

11.62

P/E (forward)

6.67

EPS (trailing)

$3.33

Dividend yield

3.06%

Beta

0.24

Avg. volume

761.0K

Ex-dividend date

May 22, 2026

Dividend pay date

June 8, 2026

Forecasts

7 analyst ratings

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Competitors

Chosen by industry and closest market cap.

• FMS

  Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

  $23.07

  ▼ 0.86%
  Market cap $13.46BP/E 11.62
  $34.57$47.86
• DVA

  DaVita Inc. Common Stock

  $180.7

  ▲ 1.02%
  Market cap $11.53BP/E 13.64
  $101$247.49
• SHC

  Sotera Health Company Common Stock

  $19.27

  ▼ 1.08%
  Market cap $5.39BP/E 46.08
  $13.09$19.85
• AGL

  agilon health inc. Common Stock

  $91.93

  ▼ 2.39%
  Market cap $1.45BP/E —
  $7.48$133.04
• VMD

  Viemed Healthcare Inc. Common Shares

  $8.84

  ▼ 1.89%
  Market cap $362.60MP/E 24.70
  $6.05$12.61
• NIVF

  NewGenIvf Group Limited Class A Ordinary Shares

  $0.4085

  ▼ 12.71%
  Market cap $3.36MP/E 0.33
  $0.403$2,052

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Fresenius Medical Care Publishes Global Study On Hemodiafiltration Associated With Lower Relative Risk Of Death From Conventional High-Flux Hemodialysis
  benzinga · 8/27/2026
• Fresenius Medical Care Publishes Global Study On Hemodiafiltration Associated With Lower Relative Risk Of Death From Conventional High-Flux Hemodialysis
  Benzinga · 8/27/2026
• Fresenius Medical Care AG 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/7/2026
• Bernstein Maintains Market Perform on Fresenius Medical Care, Raises Price Target to $25.8
  Benzinga · 8/6/2026
• Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/4/2026
• Fresenius Medical Care Q2 2026 Earnings Call Transcript
  Benzinga · 8/4/2026
• Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
  Benzinga · 8/4/2026
• Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est
  Benzinga · 8/4/2026
• Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B Estimate
  Benzinga · 8/3/2026

Institutional Ownership

March 31, 2026

Total shares held

42.13M

Total value held

$928.01M

Institutional holders

215